Author:
Guo Wei-Jian,Qi Hui,Deng Chun-Yan,Zhou Han-Xin,Deng Shao-Ping,Li Fu-Rong
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Davies JD, O’Connor E, Hall D, Krahl T, Trotter J, Sarvetnick N. CD4+CD45RB low-density cells from untreated mice prevent acute allograft rejection. J Immunol. 1999;163:5353–7.
2. Luke PP, Deng JP, Lian D, O’Connell PJ, Garcia B, Jevnikar AM, Zhong R. Prolongation of allograft survival by administration of anti-CD45RBmAb monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-Cell proportions. Am J Transplant. 2006;6:2023–34.
3. Lazarovits AI, Poppema S, Zhang Z, Khandaker M, Le Feuvre CE, Singhal SK, Garcia BM, Ogasa N, Jevnikar AM, White MH, Singh G, Stiller CR, Zhong RZ. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature. 1996;380:717–20.
4. Lee KM, Yeh H, Zhao G, Wei L, O’Connor M, Stott RT, Soohoo J, Dunussi K, Fiorina P, Deng S, Markmann JF, Kim JI. B-cell depletion improves islet allograft survival with anti-CD45RB. Cell Transplant. 2014;23(1):51–8.
5. Basadonna GP, Auersvald L, Khuong CQ, Zheng XX, Kashio N, Zekzer D, Minozzo M, Qian H, Visser L, Diepstra A, Lazarovits AI, Poppema S, Strom TB, Rothstein DM. Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. Proc Natl Acad Sci. 1998;95:3821–6.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献